We observed that adherent MCF7 breast cancer cells grew, on average, 20% more slowly over the course of 7 days following CBX2 siRNA knockdown relative to a scrambled siRNA control (Fig. 5, three-way ANOVA, P-value = 7.0 × 10−7). Here, CBX2 is linked to breast carcinoma.